RecruitingNCT02497534

Biomarkers in Friedreich's Ataxia


Sponsor

University of Florida

Enrollment

203 participants

Start Date

Sep 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this project is to characterize measures of cardiac performance and neuromuscular physiology in FA patients using novel techniques, including echocardiography and magnetic resonance imaging (MRI), metabolic exercise testing, and neurophysiological outcomes.


Eligibility

Min Age: 6 YearsMax Age: 70 Years

Inclusion Criteria4

  • Genetic diagnosis of Friedreich's ataxia by DNA sequencing, mutational analysis or protein assay OR be a healthy subject with no evidence of a neuromuscular disorder
  • Between the ages of 6 and 70 (inclusive)
  • Are able to tolerate metabolic exercise testing
  • Are stable on cardiac medication regimen for 3 months prior to screening

Exclusion Criteria3

  • Presence of unstable heart disease
  • Receipt of cardiac transplant
  • Any concurrent medical condition which, in the opinion of the investigators, would make the subject unsuitable for the study

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Florida

Gainesville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02497534


Related Trials